Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Both lasers are equally effective and safe for treating freckles.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The supplement may help hair growth and is safe, but more research is needed.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Fullerenes show potential in skin care but need more safety research.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Cedrol nanoemulsions effectively treat hair loss by promoting hair growth and reducing DHT levels safely.

The JCCP wants new rules for the UK aesthetics industry to improve safety and standards.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Clinicians should understand tattoos to manage health issues, as tattoos can cause complications and affect medical assessments.

Some off-label treatments increase hair density, but long-term safety unknown.

Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

PRP therapy helps heal pediatric surgical wounds faster and with fewer scars but needs more research for safety and cost.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

Spironolactone plus finasteride reduces hirsutism more effectively.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Bimatoprost effectively and safely improves eyebrow appearance.